Clinical trial
Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of…
NCT00110682 · Derm Research @ 888 Inc., Industry · Completed
Key facts
| NCT number | NCT00110682 |
|---|---|
| Title | Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses |
| Official title | A Randomized, Parallel-Group, Vehicle-Controlled, Double-Blind Study of Topical Imiquimod 5% Cream Used as an Adjunct to Cryotherapy in the Management of Actinic Keratoses, With a Long-Term (1 Year) Follow-Up |
| Lead sponsor | Derm Research @ 888 Inc., Industry |
| Collaborators | 3M Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Keratosis, Actinic Keratosis |
| Intervention type | Drug |
| Interventions | Imiquimod used as an adjunct to cryotherapy |
| Enrollment | 60 |
| Start date | Apr 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | May 13, 2005 |
| Last update posted | Apr 24, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: